about
Pharmacological interventions for clozapine-induced hypersalivationPharmacological interventions for clozapine-induced hypersalivationDrooling in Parkinson's disease: a review.RimabotulinumtoxinB in sialorrhea: systematic review of clinical trialsClozapine: Current perspective.Sialorrhea - therapeutic drug options.Safety and tolerability of antipsychotic polypharmacy.A review of clozapine safety.Clozapine-induced hypersalivation: an estimate of prevalence, severity and impact on quality of lifeClozapine use in a forensic population in a New South Wales prison hospital.A review and assessment of drug-induced parotitis.A successful treatment strategy for clozapine-induced parotid swelling: a clinical case and systematic review.Adverse effects of clozapine in older patients: epidemiology, prevention and management.The practical management of refractory schizophrenia--the Maudsley Treatment REview and Assessment Team service approach.Swallowing Disorders in Schizophrenia.A Questionnaire-based Study of the Views of Schizophrenia Patients and Psychiatric Healthcare Professionals in Japan about the Side Effects of Clozapine.Effect of Scopolamine Butylbromide on Clozapine-induced Hypersalivation in Schizophrenic Patients: A Case Series.Quetiapine-induced hypersalivation.Amisulpride augmentation for clozapine-refractory positive symptoms: additional benefit in reducing hypersialorrhea.The combined use of risperidone long-acting injection and clozapine in patients with schizophrenia non-adherent to clozapine: a case series.Ipratropium bromide for treatment of bethanechol-induced sialorrhea.Amisulpride versus moclobemide in treatment of clozapine-induced hypersalivation.
P2860
Q24242126-674C2685-DA6E-4170-99AD-026FFD64D1D0Q24245171-758246B1-D650-4598-9522-0CCC10A52517Q27691412-96332D4E-E49A-4D85-A458-25E35D7FDE2FQ33768467-F364326C-BD62-4F64-B8E6-5FD050E255BDQ34021447-04C98489-34CB-4300-B567-680D8A5951BBQ34156159-3EAAFE60-99F0-4A1D-BAC2-016486BF9988Q36062421-96BC4DB2-6541-40FE-97E3-584B03BA8490Q36191044-EBA89D8A-79C9-42FB-BFA4-E790C0256777Q37011466-DCC27A51-E75C-41C4-AB8F-EB167554D1C3Q37057976-FE240ACC-0400-46A6-AC77-A63D2D645F7FQ38068296-5D560A8C-29A6-4E31-9C4A-C5CC89FAD50FQ38132166-EC4EA1A6-ED08-48FB-AD76-C5118BAB8F4FQ38171350-407E829D-20FE-4F08-80C0-81B909B29EC9Q38247122-CE0BDF40-FD69-4CFE-A613-41B5CF84EDD9Q39266028-318CCB52-8E0D-41ED-92BE-6104715E8534Q39526505-8746018B-A19C-44E9-90F7-A5C94D8817E2Q40386114-F50F8C72-9BB6-419A-B6D9-63ADE06C5FBEQ42682618-1F68F9A3-097F-445F-AFDC-93754B9D6737Q43198199-2C4C97D2-4140-4FB4-A43D-E051CF2046B2Q43234864-911E6B56-1269-44B2-A20F-DFDCB586204BQ44551456-FBED541E-F4BD-4C9A-9BE3-0F2451E48D0EQ51832581-C9BB2C81-F4F7-4912-9218-8568EEC8B939
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Clozapine-induced hypersalivation.
@ast
Clozapine-induced hypersalivation.
@en
type
label
Clozapine-induced hypersalivation.
@ast
Clozapine-induced hypersalivation.
@en
prefLabel
Clozapine-induced hypersalivation.
@ast
Clozapine-induced hypersalivation.
@en
P2860
P356
P1476
Clozapine-induced hypersalivation.
@en
P2093
P2860
P304
P356
10.1345/APH.19259
P407
P577
2000-05-01T00:00:00Z